Showing 15,061 - 15,080 results of 99,975 for search '(( 50 ((ns decrease) OR (nn decrease)) ) OR ( 5 ((wt decrease) OR (a decrease)) ))', query time: 1.39s Refine Results
  1. 15061

    Five years comparation of efficacy and safety after ICL-V4c implantation for high and super high myopia correction by Qi Wan (271320)

    Published 2024
    “…No significant difference of ECD was found in the high (2823.45 ± 274.75 cells/mm<sup>2</sup>) and super-high myopia (2856.71 ± 323.53cells/mm<sup>2</sup>) at the visit of 5 years. Compared to baseline, we observed a significant increase in IOP at the 1-week follow-up, which decreased significantly at the one-month visit. …”
  2. 15062
  3. 15063

    List of Included studies. by Zahra Tajik (20752452)

    Published 2025
    “…The results show that one month after the NSPT, there was no significant difference in the mean visfatin level of GCF (SMD: -3.91, 95%CI: -9.83, 2.01, p = 0.195, I-square, 96.6%, random effect model, n = 2) and serum (SMD: -0.33, 95%CI: -0.98, 0.33, p = 0.332, fixed effect model, n = 1), but 2, 3 and 6 months after NSPT, the mean visfatin level of GCF and serum decreased significantly. There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  4. 15064

    The search strategy in three databases. by Zahra Tajik (20752452)

    Published 2025
    “…The results show that one month after the NSPT, there was no significant difference in the mean visfatin level of GCF (SMD: -3.91, 95%CI: -9.83, 2.01, p = 0.195, I-square, 96.6%, random effect model, n = 2) and serum (SMD: -0.33, 95%CI: -0.98, 0.33, p = 0.332, fixed effect model, n = 1), but 2, 3 and 6 months after NSPT, the mean visfatin level of GCF and serum decreased significantly. There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  5. 15065

    NIH score. by Zahra Tajik (20752452)

    Published 2025
    “…The results show that one month after the NSPT, there was no significant difference in the mean visfatin level of GCF (SMD: -3.91, 95%CI: -9.83, 2.01, p = 0.195, I-square, 96.6%, random effect model, n = 2) and serum (SMD: -0.33, 95%CI: -0.98, 0.33, p = 0.332, fixed effect model, n = 1), but 2, 3 and 6 months after NSPT, the mean visfatin level of GCF and serum decreased significantly. There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  6. 15066

    List of excluded studies. by Zahra Tajik (20752452)

    Published 2025
    “…The results show that one month after the NSPT, there was no significant difference in the mean visfatin level of GCF (SMD: -3.91, 95%CI: -9.83, 2.01, p = 0.195, I-square, 96.6%, random effect model, n = 2) and serum (SMD: -0.33, 95%CI: -0.98, 0.33, p = 0.332, fixed effect model, n = 1), but 2, 3 and 6 months after NSPT, the mean visfatin level of GCF and serum decreased significantly. There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  7. 15067

    Extreme acid survival of <i>S</i>. Typhi strains depends upon the pH of the pre-growth media. by Madushini N. Dharmasena (3139767)

    Published 2016
    “…Ty21a with pGad showed good survival when bacteria were pre-grown in mildly acidic pH media and in commercial unbuffered TSB, with the <i>p</i> value significance between Ty21apGad and Ty21a EV at pH 4.5, 5.5, 6.5 and 7.2 (unbuffered) are 0.0236, 0.0251, 0.0230 and 0.0468, respectively; however following pre-growth at pH 7.5, acid survival was decreased by ~ 3 logs (non-significant <i>p</i> value 0.1827). …”
  8. 15068

    αvβ5 Integrin/FAK/PGC-1α Pathway Confers Protective Effects on Retinal Pigment Epithelium by Murilo F. Roggia (755997)

    Published 2015
    “…To elucidate the mechanism, siRNAs against β5 integrin, CD36, Mer tyrosine kinase (MerTK), and Atg5, blocking antibodies against CD36 and MerTK, and a specific inhibitor for focal adhesion kinase (FAK) were used. …”
  9. 15069

    Slope coefficients of herbivore density (individuals.km<sup>-2</sup>) along a gradient of increasing woody cover (e.g. for a 10% increase in woody cover on the basalts, the impala... by Izak P. J. Smit (762687)

    Published 2015
    “…</p><p>This illustrates that browsers increase with increasing woody cover, whilst most grazers decrease. (**** 0.01% significance level; *** 0.1% significance level; ** 1% significance level; * 5% significance level; when applying a Bonferroni correction for 24 tests, only species indicated as significant at the ≤0.1% level will remain significant at the 5% level).…”
  10. 15070
  11. 15071
  12. 15072
  13. 15073
  14. 15074
  15. 15075
  16. 15076
  17. 15077
  18. 15078

    Presentation_1_Risk of severe COVID-19 infection in persons with diabetes during the first and second waves in Denmark: A nationwide cohort study.pdf by Jacob V. Stidsen (8560017)

    Published 2022
    “…However, when mortality was restricted to the hospitalized population, the crude mortality fell from 26.8% to 19.6% in persons with diabetes, while only a minor decrease was seen in persons without diabetes (from 16.7% to 15.5%).…”
  19. 15079
  20. 15080

    Effects of Prednisolone on Disease Progression in Antiretroviral-Untreated HIV Infection: A 2-Year Randomized, Double-Blind Placebo-Controlled Clinical Trial by Christa Kasang (345821)

    Published 2016
    “…Secondary endpoints: Prednisolone-treatment decreased immune activation (sCD14, suPAR, CD38/HLA-DR/CD8+) and increased CD4-counts (+77.42 ± 5.70 cells/μl compared to -37.42 ± 10.77 cells/μl under placebo, p < 0.0001). …”